Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope

Nature

Volumn 435, Issue 7039, 2005, Pages 224-228

  Kent, Sally C ^a   Chen, Yahua ^a   Bregoli, Lisa ^a   Clemmings, Sue M ^b   Kenyon, Norma Sue ^c   Ricordi, Camillo ^c   Hering, Bernhard J ^b   Hafler, David A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; INSULIN; PATHOLOGY;

AUTOIMMUNE; PANCREATIC DRAINING LYMPH; PANCREATIC LYMPH NODES; T CELLS;

CELLS;

AUTOANTIGEN; EPITOPE; HLA DR4 ANTIGEN; INSULIN; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

DIABETES; MEDICINE;

ADULT; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; CELL DESTRUCTION; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE; LYMPHOCYTE CLONE; MALE; PANCREAS; PANCREAS ISLET BETA CELL; PANCREATIC LYMPH NODE; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; ALLELE; AMINO ACID SEQUENCE; CASE CONTROL STUDY; CELL CLONE; CHEMISTRY; CYTOLOGY; ENZYME SPECIFICITY; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS; PATHOLOGY;

ALLELES; AMINO ACID SEQUENCE; CASE-CONTROL STUDIES; CLONE CELLS; DIABETES MELLITUS, TYPE 1; EPITOPES, T-LYMPHOCYTE; HLA-DR ANTIGENS; HUMANS; INSULIN; LYMPH NODES; MOLECULAR SEQUENCE DATA; PANCREAS; RECEPTORS, ANTIGEN, T-CELL; SUBSTRATE SPECIFICITY; T-LYMPHOCYTES;

EID: 18744385526     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03625     Document Type: Article

References (32)

1. Atkinson, M. A. & Maclaren, N. K. The pathogenesis of insulin-dependent diabetes mellitus. N. Engl. J. Med. 331, 1428-1436 (1994).
2. Eisenbarth, G. S. Type I diabetes mellitus: a chronic autoimmune disease. N. Engl. J. Med. 314, 1360-1368 (1986).
3. Hoglund, P. et al. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J. Exp. Med. 189, 331-339 (1999).
4. Thomson, G. et al. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am. J. Hum. Genet. 43, 799-816 (1988).
5. Katz, J. D., Wang, B., Haskins, K., Benoist, C. & Mathis, D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74, 1089-1100 (1993).
6. Acha-Orbea, H. & McDevitt, H. O. The role of class II molecules in development of insulin-dependent diabetes mellitus in mice, rats and humans. Curr. Top. Microbiol. Immunol. 156, 103-119 (1990).
7. Haskins, K., Portas, M., Bergman, B., Lafferty, K. & Bradley, B. Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc. Natl Acad. Sci. USA 86, 8000-8004 (1989).
8. Wegmann, D. R., Norbury-Glaser, M. & Daniel, D. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur. J. Immunol. 24, 1853-1857 (1994).
9. Londei, M. et al. Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc. Natl Acad. Sci. USA 86, 636-640 (1989).
10. Dayan, C. M. et al. Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc. Natl Acad. Sci. USA. 88, 7415-7419 (1991).
11. Hafler, D. A. et al. Oligoclonal T-lymphocytes in the cerebrospinal fluid of patients with inflammatory central nervous system diseases. J. Exp. Med. 167, 1625-1644 (1988).
12. Roep, B. O. T-cell responses to autoantigens in IDDM. Diabetes 45, 1147-1156 (1996).
13. Wong, F. S. et al. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nature Med. 5, 1026-1031 (1999).
14. Todd, J. A., Bell, J. I. & McDevitt, H. O. HLA antigens and insulin-dependent diabetes. Nature 333, 710 (1988).
15. Schloot, N. C. et al. Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells. Report of the third immunology of diabetes society T-cell workshop. J. Autoimmun. 21, 365-376 (2003).
16. Peakman, M. et al. Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: report of phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell assays in type I diabetes. Diabetes 50, 1749-1754 (2001).
17. Eisenbarth, G. S. et al. Insulin autoimmunity: prediction/precipitation/ prevention type IA diabetes. Autoimmun. Rev. 1, 139-145 (2002).
18. Harrison, L. C. et al. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes. J. Clin. Invest. 89, 1161-1165 (1992).
19. Astill, T. P., Ellis, R. J., Arif, S., Tree, T. I. M. & Peakman, M. Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and- protective HLA class II molecules. Diabetologia 46, 496-503 (2003).
20. Endl, J. et al. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J. Clin. Invest. 15, 2405-2415 (1997).
21. Mycko, M. P. et al. Cross-reactive TCR responses to self antigens presented by different MHC class II molecules. J. Immunol. 173, 1689-1698 (2004).
22. Tian, J., Lehmann, P. & Kaufman, D. Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens. J. Exp. Med. 186, 2039-2043 (1997).
23. Nakano, N., Kikutani, H., Nishimoto, H. & Kishimoto, T. T cell receptor V gene usage of islet β cell-reactive T cells is not restricted in non-obese diabetic mice. J. Exp. Med. 173, 1091-1097 (1991).
24. Miyazaki, A. et al. Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study. Clin. Exp. Immunol. 60, 622-630 (1985).
25. Candeias, S., Katz, J., Benoist, C., Mathis, D. & Haskins, K. Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors. Proc. Natl Acad. Sci. USA 88, 6167-6170 (1991).
26. Baker, F., Lee, M., Chien, Y.-h. & Davis, M. Restricted islet-cell reactive T cell repetoire of early pancreatic islet infiltrates in NOD mice. Proc. Natl Acad. Sci. USA 99, 9374-9379 (2002).
27. Sibley, R. K., Sutherland, D. E., Goetz, F. & Michael, A. F. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab. Invest. 53, 132-144 (1985).
28. Jaeckel, E., Lipes, M. A. & von Boehmer, H. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nature Immunol. 5, 1028-1035 (2004).
29. Nakayama, M. et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature doi:10.1038/nature03523 (this issue).
30. Yoon, J. W. et al. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science 284, 1183-1187 (1999).
31. + T cells. J. Immunol. 163, 301-311 (1999).
32. Akatsuka, Y., Martin, E., Madonik, A., Barsoukov, A. & Hansen, J. Rapid screening of T-cell receptor (TCR) variable gene usage by multiplex PCR: application for assessment of clonal composition. Tissue Antigens 53, 122-134 (1999).